FDA warn company about illegally marketing CBD products
FDA have issued a letter to Curaleaf, warning the company about misleading the public with ‘unsubstantiated claims’ concerning the benefits of CBD.
View original article
Contributor:
FDA have issued a letter to Curaleaf, warning the company about misleading the public with ‘unsubstantiated claims’ concerning the benefits of CBD.
View original article
Contributor: